A cardiac MRI of athletes who had COVID-19 is seven times more effective in detecting inflammation of the heart than symptom-based testing, according to a study led by researchers at The Ohio State University Wexner Medical Center and College of Medicine with 12 other Big Ten programs. The findings are published online by JAMA Cardiology. This...
Simple protocol can improve medicinal treatment for opioid addiction
by Michel Morris, Johns Hopkins University School of Medicine Johns Hopkins Medicine researchers have found that increasing the use of evidence-based medications — therapeutic drugs proven by scientific evidence — may significantly improve care for those with opioid dependence. Credit: Public domain image Unintentional overdoses are the leading cause of death for Americans under 50, with...
FDA authorizes third Covid antibody treatment that cuts risk of hospitalization or death by 85%
By MANSUR SHAHEEN FOR DAILYMAIL.COM PUBLISHED: 18:04 EDT, 27 May 2021 | UPDATED: 18:05 EDT, 27 May 2021 The U.S. Food and Drug Administration (FDA) has authorized the third monoclonal antibody drug to treat COVID-19. Sotrovimab, which was developed by Vir Biotechnology Inc. and GlaxoSmithKline PLC, is believed to able to reduce COVID-19 hospitalizations and deaths by up to 85 percent. It...
Technology to monitor mental wellbeing might be right at your fingertips
TEXAS A&M UNIVERSITY To help patients manage their mental wellness between appointments, researchers at Texas A&M University have developed a smart device-based electronic platform that can continuously monitor the state of hyperarousal, one of the signs of psychiatric distress. They said this advanced technology could read facial cues, analyze voice patterns and integrate readings from...
Autism Spectrum Disorder – National database reveals a cumulative incidence of 2.75%
SHINSHU UNIVERSITY Analysis using a national medical database revealed that the cumulative incidence of autism spectrum disorders (ASD) in children born in 2009-2014 was 2.75% by the age of five. A research group led by Associate Professor Daimei Sasayama and Professor Hideo Honda of the Department of Child and Adolescent Development Psychiatry, Shinshu University School...
AGA recommends early use of biologics in patients with moderate-to-severe Crohn’s disease
AMERICAN GASTROENTEROLOGICAL ASSOCIATION IMAGE: MEDICAL MANAGEMENT OF MODERATE TO SEVERE LUMINAL AND PERIANAL FISTULIZING CROHN’S DISEASE CREDIT: AMERICAN GASTROENTEROLOGICAL ASSOCIATION Bethesda, MD (May 27, 2021) — Crohn’s disease, a type of inflammatory bowel disease (IBD) that causes inflammation (pain and swelling) in the gastrointestinal tract, can cause daily health problems, frequent hospitalizations and surgery when...
Benefits of immunotherapy combination persist for more than six years in advanced melanoma
DANA-FARBER CANCER INSTITUTE Higher percentage of patients treated with nivolumab and ipilimumab in clinical trial reach the six-and-a-half-year survival mark than those treated with either drug alone. BOSTON – In the longest follow-up results from a clinical trial of combination immunotherapy for metastatic melanoma, investigators report that nearly half the patients who received the drugs nivolumab and ipilimumab were...
Automating ringworm diagnosis
by David Bradley, Inderscience Credit: CC0 Public Domain Ringworm, known more correctly as dermatophytosis, is a skin infection caused by any of forty or so different types of microbial fungus. It causes inflammation and itchiness, making the skin scaly and forming a circular rash, and sometimes causing hair loss and blistering. Typical infection is by Trichophyton,...
Low on antibodies, blood cancer patients can fight off COVID-19 with T cells
by Perelman School of Medicine at the University of Pennsylvania Credit: Pixabay/CC0 Public Domain Antibodies aren’t the only immune cells needed to fight off COVID-19—T cells are equally important and can step up to do the job when antibodies are depleted, suggests a new Penn Medicine study of blood cancer patients with COVID-19 published in Nature Medicine....
WHY DO COVID VACCINES SEEM TO WORK BETTER FOR MEN?
If there’s one take-home message for the general public about the coronavirus vaccines approved in the US, it’s that they are remarkably effective. But Michigan State University’s Morteza Mahmoudi is raising awareness about an important subtlety: The vaccines developed by Moderna and Pfizer-BioNTech appear to work slightly better for males than for females. Both vaccines...